25/250 SP 343 (Parcopa 25 mg / 250 mg)

Generic Name: carbidopa/levodopa

Pill imprint 25/250 SP 343 has been identified as Parcopa 25 mg / 250 mg.

Parcopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Parcopa 25 mg / 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 25/250 SP 343 (Parcopa 25 mg / 250 mg)

Parcopa 25 mg / 250 mg 25/250 SP 343
Parcopa
Generic Name:
carbidopa/levodopa
Imprint:
25/250
SP 343
Strength:
25 mg / 250 mg
Color:
Blue
Size:
14.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Schwarz Pharma
National Drug Code (NDC):
00091-3343
Inactive Ingredients:
aspartame
citric acid
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
natural mint flavor
artificial mint flavor
sodium bicarbonate
FD&C Blue No. 2 Aluminium Lake
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
18860-0343 Azur Pharma Inc

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Learn how medication, diet, and exercise are key to managing Multiple Sclerosis. Click Here

Close
Hide
(web2)